The clinical trial, involving 40 patients at the Singapore General Hospital (SGH) and the National Cancer Centre Singapore ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Massey Comprehensive Cancer Center have discovered a new genetic target that could possibly shape the future of treatment for liver ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...

In a remarkable twist of science, researchers have transformed a fungus long associated with death into a potential weapon ...

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...

Affiliates: Chan Zuckerberg Biohub New York, Vagelos Institute for Biomedical Research, Irving Institute for Clinical and Translational Research, Vagelos College of Physicians and Surgeons Departments ...

Corewell Health in Grand Rapids begins offering histotripsy, a new non-invasive liver cancer treatment. Gavin Newsom mocks Trump's "made in China" smartphone Melissa Rauch Eulogizes ‘Night Court ...

A RECENT international Phase 3 clinical trial has demonstrated that a combination of toripalimab and bevacizumab significantly improves survival outcomes in patients with previously untreated advanced ...